Latest News

Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Richmond Pharmacology Opens New London Bridge Site

March 2017

This decision marks the next step in Richmond Pharmacology’s continued growth, having already conducted over 300 studies in London since 2001, often in rare disease areas such as amyloidosis.

View article

Accelerated Early Phase Drug Development in the UK and Europe

November 2016

Hear the latest updates about how early phase studies can be accelerated globally by starting first in human trials in the UK then rapidly progress into Europe. This will give you access to a population of 500 million people.

View article

Inotrem successfully completes its first phase I clinical trial with Motrem™, a TREM-1 pathway modulator for the treatment of septic shock

September 2016

Paris, France, September 13, 2016

View article

Futura Medical plc announce headline results from its efficacy study of the Company's novel gel for the treatment of erectile dysfunction

September 2016

<p></p>

View article

Access 500 million patients. Regulators, sponsors....

March 2016

Organised by the British Consulate Boston; The Medicines and Healthcare products Regulatory Agency (MHRA), sponsors and investigators came together...

View article

No Triumph Without Trials: The Fight Against Cancer

February 2016

In the last 70 years, the development of clinical cancer research has been remarkable.

View article

Low data variability

Exceptional ECG generation

Experts in cardiac safety

Our specialist services

News

Stay up to date with the latest activity at Richmond Pharmacology

Richmond Pharmacology Opens New London Bridge Site

Accelerated Early Phase Drug Development in the UK and Europe

Inotrem successfully completes its first phase I clinical trial with Motrem™, a TREM-1 pathway modulator for the treatment of septic shock

Futura Medical plc announce headline results from its efficacy study of the Company's novel gel for the treatment of erectile dysfunction

Access 500 million patients. Regulators, sponsors....

No Triumph Without Trials: The Fight Against Cancer

主要メンバー紹介

リッチモンドでのキャリア

動画紹介

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

私たちについて

ナレッジベース

ソーシャルメディア